Compare GSK plc (GSK) vs Super Micro Computer Inc (SMCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Super Micro Computer Inc — how do they compare? GSK plc trades at $52.67 (market cap $101.34B), while Super Micro Computer Inc trades at $25.04 (market cap $17.39B). The key difference: GSK plc is far larger — about 5.8× Super Micro Computer Inc's market cap, and GSK plc pays a 3.49% dividend while Super Micro Computer Inc pays none. Which is the better fit depends on your goals.
| GSK | SMCI | |
|---|---|---|
Market Cap | $101.34B | $17.39B |
Sector | Health | Technology |
52-Week High | $61.18 | $60.71 |
52-Week Low | $36.20 | $20.53 |
Enterprise Value | $121.95B | $24.91B |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
Super Micro Computer (SMCI) trades at $25.87, down 6.44% on the day and 56% from its 52-week high, reflecting significant recent pressure. The stock shows bearish technical signals with support at $24-$26, while fundamentals reveal strong revenue growth but margin compression and cash flow concerns. Recent news highlights a Taiwan export probe, competitive pressures in AI hardware, and a sharp sector pullback.
The outlook is mixed: valuation appears attractive with a P/E of 14.15 and P/S of 0.53, and analyst consensus targets $36.71 (42% upside). However, risks are elevated from inventory build-up, cash conversion challenges, legal investigations, and intense AI server competition. The stock offers speculative value for risk-tolerant investors betting on execution improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Super Micro Computer Inc
Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →
